294 results
8-K
EX-99.1
AGEN
Agenus Inc
14 Mar 24
Agenus Reports Fourth Quarter and Full Year 2023 Results
7:32am
by priming and activating T cells, downregulating intratumoral regulatory T cells, activating myeloid cells and inducing long-term memory responses
8-K
EX-99.1
AGEN
Agenus Inc
15 Feb 24
Regulation FD Disclosure
8:00am
Exhibit 99.1
February 15, 2024
To Our Valued Shareholders,
Agenus is committed to enhancing shareholder value and securing the long-term success
8-K
EX-99.1
ks1a8e
7 Nov 23
Results of Operations and Financial Condition
6:30am